The impact of bone metastases and SREs

Skeletal complications associated with bone metastases can increase the risk of mortality.

Learn more >

Aromatase inhibitors (Als) improve disease-free survival but increase bone loss

Women with breast cancer who are taking Al therapy have an increased fracture risk.

Learn more >

RANK Ligand and the biology of bone destruction

RANK Ligand is key to the development and activation of osteoclasts and plays a key role in bone loss.

Watch the video >